In contrary to other studies on Treg levels in peripheral blood of CRC patients and HD (24, 29), we did not find any significant difference between relative percentages of Tregs expressing FoxP3 between CRC patients and HD (2.7 ± 0.3%; Figure 3A). The gene discussed is FOXP3; the disease is colorectal carcinoma.